Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular Diseases-Reference-Cited by-同舟云学术

Therapeutic Agents Targeting Cardiometabolic Risk for Preventing and Treating Atherosclerotic Cardiovascular Diseases

Published:2018-06-19 Issue:2 Volume:104 Page:257-268
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Arsenault Benoit J.¹²,Perrot Nicolas¹²,Puri Rishi³⁴

Affiliation:

1. Centre de recherche de l'Institut universitaire de cardiologie et de pneumologie de Québec; Canada

2. Department of Medicine, Faculty of Medicine; Université Laval; Québec Canada

3. Department of Cardiovascular Medicine; Cleveland Clinic; Ohio USA

4. Department of Medicine; University of Adelaide; SA Australia

Funder

Canadian Institutes of Health Research

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.1110/fullpdf

Reference87 articles.

1. Decline in deaths from heart disease and stroke - United States, 1900-1999;Morbid. Mortal. Wkly. Rep.,1999

2. Decline in cardiovascular mortality: possible causes and implications;Mensah;Circ. Res.,2017

3. Receptor-mediated control of cholesterol metabolism;Brown;Science,1976

4. Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity;Endo;FEBS Lett.,1976

5. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S);Lancet,1994

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Inflammatory Effects of Lipid-Lowering Drugs and Supplements—A Narrative Review;Nutrients;2023-03-21

2. Bempedoic Acid’s Use as an Adjunct in Lowering Low-Density Lipoprotein Cholesterol in Patients With Coronary Artery Disease: A Systematic Review;Cureus;2022-10-04

3. Effect of PCSK9 Inhibitor on Blood Lipid Levels in Patients with High and Very-High CVD Risk: A Systematic Review and Meta-Analysis;Cardiology Research and Practice;2022-04-26

4. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia;Nature Reviews Cardiology;2022-03-22

5. Evinacumab for the treatment of homozygous familial hypercholesterolemia;Expert Review of Clinical Pharmacology;2022-02-01